Detailed answers about EXCELLERATE BIOSCIENCE HOLDINGS LIMITED, including incorporation, status, business activity, and accounts information.
When was EXCELLERATE BIOSCIENCE HOLDINGS LIMITED founded?
EXCELLERATE BIOSCIENCE HOLDINGS LIMITED was officially incorporated on 21 November 2019 and is registered under company number 12326225. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is EXCELLERATE BIOSCIENCE HOLDINGS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of EXCELLERATE BIOSCIENCE HOLDINGS LIMITED?
EXCELLERATE BIOSCIENCE HOLDINGS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does EXCELLERATE BIOSCIENCE HOLDINGS LIMITED do?
EXCELLERATE BIOSCIENCE HOLDINGS LIMITED operates in the following sectors: 64209 - Activities of other holding companies n.e.c., 72110 - Research and experimental development on biotechnology. These SIC codes provide insight into the company's business activities and industry focus.
What is EXCELLERATE BIOSCIENCE HOLDINGS LIMITED's registered address?
The registered office address of EXCELLERATE BIOSCIENCE HOLDINGS LIMITED is NG2 BUSINESS PARK, 21 THE TRIANGLE, NOTTINGHAM, ENGLAND, NG2 1AE. This is the official address filed with Companies House for legal and statutory correspondence.
Is EXCELLERATE BIOSCIENCE HOLDINGS LIMITED financially stable?
The most recent accounts for EXCELLERATE BIOSCIENCE HOLDINGS LIMITED were made up to 30 June 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 March 2026.